Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose levodopa to enhance motor learning
NL-OMON46724Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of levodopa and carbidopa (2 arms), sponsored by Erasmus MC. Primary endpoints: Velocity of motor adaptation, Gain of motor adaptation and 4 more. Planned start May 2018; status: not yet recruiting.
02
Drugs
levodopacarbidopa
Beyond the preview
Go deeper on NL-OMON46724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46724.